These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
443 related articles for article (PubMed ID: 17893685)
1. Alcohol septal ablation versus surgical myectomy: a patient with obstructive HCM. La Canna G; Airoldi F; Capritti E; Grimaldi A; Colombo A; Alfieri O Nat Clin Pract Cardiovasc Med; 2007 Oct; 4(10):570-6. PubMed ID: 17893685 [TBL] [Abstract][Full Text] [Related]
2. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717 [TBL] [Abstract][Full Text] [Related]
3. Myectomy for hypertrophic obstructive cardiomyopathy after failed alcohol septal ablation: clinicopathological correlations. Arrazaghi AA; Butany JW; Williams WG; Wigle DE; Rakowski H Can J Cardiol; 2001 Feb; 17(2):197-202. PubMed ID: 11223490 [TBL] [Abstract][Full Text] [Related]
4. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue. Talreja DR; Nishimura RA; Edwards WD; Valeti US; Ommen SR; Tajik AJ; Dearani JA; Schaff HV; Holmes DR J Am Coll Cardiol; 2004 Dec; 44(12):2329-32. PubMed ID: 15607394 [TBL] [Abstract][Full Text] [Related]
5. Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysis. van Dockum WG; Kuijer JP; Götte MJ; Ten Cate FJ; Ten Berg JM; Beek AM; Twisk JW; Marcus JT; Visser CA; van Rossum AC Eur Heart J; 2006 Dec; 27(23):2833-9. PubMed ID: 17098761 [TBL] [Abstract][Full Text] [Related]
7. Myectomy for hypertrophic obstructive cardiomyopathy. McRae ME Can J Cardiovasc Nurs; 2007; 17(2):22-30. PubMed ID: 17583317 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and coronary artery disease. Nambi V; Buergler JM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF Am J Cardiol; 2005 Aug; 96(4):580-1. PubMed ID: 16098315 [TBL] [Abstract][Full Text] [Related]
9. [Percutaneous transluminal septal ablation with ethanol in hypertrophic obstructive cardiomyopathy: a case report]. Sakakibara M; Abe S; Fusegawa Y; Nakajima T; Iwata O; Goto S; Shiina Y; Handa S J Cardiol; 1999 Jul; 34(1):35-40. PubMed ID: 10422624 [TBL] [Abstract][Full Text] [Related]
10. [Long-term outcome of a patient with hypertrophic obstructive cardiomyopathy treated by alcohol septal transcoronary ablation]. Pillière R; Gerardin B; Petitier H; Hue S; Raymond P; N'Guyen A; Dubourg O Arch Mal Coeur Vaiss; 2002 Mar; 95(3):213-7. PubMed ID: 11998337 [TBL] [Abstract][Full Text] [Related]
11. [Effectivness of transcatheter alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy]. Chernov SA; Kucherov VV; Fursov AN; Zakharova EG; Gaĭdukov AV; Liapkova NB; Korneev NV; Pestovskaia OR Voen Med Zh; 2009 Feb; 330(2):28-35. PubMed ID: 19351021 [No Abstract] [Full Text] [Related]
12. Commentary and re-appraisal: surgical septal myectomy vs. alcohol ablation: after a decade of controversy and mismatch between clinical practice and guidelines. Maron BJ Prog Cardiovasc Dis; 2012; 54(6):523-8. PubMed ID: 22687595 [No Abstract] [Full Text] [Related]
13. Long-term effects of varying alcohol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy: a randomized study with a follow-up up to 11 years. Veselka J; Tomašov P; Zemánek D Can J Cardiol; 2011; 27(6):763-7. PubMed ID: 22000583 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Faber L Eur J Med Res; 2006 Oct; 11(10):423-31. PubMed ID: 17107876 [TBL] [Abstract][Full Text] [Related]